A qualitative immunohistochemical (IHC) assay using a monoclonal antibody against alpha-methylacyl-CoA racemase (AMACR), also known as P504S, aims to detect elevated AMACR protein expression in prostate tissue. AMACR is a commonly used marker to support the diagnosis of prostate cancer, particularly in small biopsies or suspected cases.